[go: up one dir, main page]

EE200300005A - Meetod konformse haiguse diagnoosimiseks või tuvastamiseks, selleks vajalik katsemenetlus, reaktiivikomplekt ning seade - Google Patents

Meetod konformse haiguse diagnoosimiseks või tuvastamiseks, selleks vajalik katsemenetlus, reaktiivikomplekt ning seade

Info

Publication number
EE200300005A
EE200300005A EEP200300005A EEP200300005A EE200300005A EE 200300005 A EE200300005 A EE 200300005A EE P200300005 A EEP200300005 A EE P200300005A EE P200300005 A EEP200300005 A EE P200300005A EE 200300005 A EE200300005 A EE 200300005A
Authority
EE
Estonia
Prior art keywords
diagnosis
detection
test procedure
reagent kit
required test
Prior art date
Application number
EEP200300005A
Other languages
English (en)
Inventor
Soto Claudio
Saborio Gabriella
Original Assignee
Applied Research Systems Ars Holding N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems Ars Holding N.V. filed Critical Applied Research Systems Ars Holding N.V.
Publication of EE200300005A publication Critical patent/EE200300005A/et
Publication of EE05675B1 publication Critical patent/EE05675B1/et

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EEP200300005A 2000-07-07 2001-06-13 Meetod konformse haiguse diagnoosimiseks v?i tuvastamiseks, selleks vajalik katsemenetlus, reaktiivikomplekt ning seade EE05675B1 (et)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP00114650 2000-07-07
EP00127892 2000-12-20
EP01102732 2001-02-07
PCT/GB2001/002584 WO2002004954A2 (en) 2000-07-07 2001-06-13 Early diagnosis of conformational diseases

Publications (2)

Publication Number Publication Date
EE200300005A true EE200300005A (et) 2004-08-16
EE05675B1 EE05675B1 (et) 2013-08-15

Family

ID=27223071

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300005A EE05675B1 (et) 2000-07-07 2001-06-13 Meetod konformse haiguse diagnoosimiseks v?i tuvastamiseks, selleks vajalik katsemenetlus, reaktiivikomplekt ning seade

Country Status (30)

Country Link
US (1) US7351526B2 (et)
EP (2) EP1299729B1 (et)
JP (1) JP4790966B2 (et)
KR (1) KR100764981B1 (et)
CN (1) CN1221807C (et)
AR (1) AR029583A1 (et)
AT (2) ATE426816T1 (et)
AU (2) AU6408901A (et)
BG (1) BG66272B1 (et)
BR (1) BRPI0112262B8 (et)
CA (1) CA2413078C (et)
CY (1) CY1109106T1 (et)
CZ (1) CZ304365B6 (et)
DE (2) DE60138146D1 (et)
DK (2) DK1712920T3 (et)
EA (1) EA007391B1 (et)
EE (1) EE05675B1 (et)
ES (2) ES2322660T3 (et)
HR (1) HRP20030033B1 (et)
HU (1) HU228813B1 (et)
IL (2) IL153824A0 (et)
MX (1) MXPA03000226A (et)
NO (1) NO331624B1 (et)
NZ (1) NZ523213A (et)
PL (1) PL211154B1 (et)
PT (2) PT1299729E (et)
RS (1) RS51523B (et)
SI (2) SI1712920T1 (et)
SK (1) SK287768B6 (et)
WO (1) WO2002004954A2 (et)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002073210A1 (de) * 2001-03-13 2002-09-19 Manfred Eigen Verfahren zur verstärkung der bildung von aggregaten aus proteinuntereinheiten
US7166471B2 (en) 2001-05-31 2007-01-23 Arete Associates Misfolded protein sensor method in body fluids
US20050026165A1 (en) * 2001-05-31 2005-02-03 Cindy Orser Detection of conformationally altered proteins and prions
WO2004111652A1 (en) 2003-06-19 2004-12-23 Applied Research Systems Ars Holding N.V. Use of prion conversion modulating agents
DE10328125A1 (de) * 2003-06-23 2005-01-13 Roche Diagnostics Gmbh Nachweis von Protease-resistentem Prion-Protein nach spontaner Transformationsreaktion
DE10328830A1 (de) * 2003-06-26 2005-01-20 Roche Diagnostics Gmbh Nachweis von Protease-resistentem Prion-Protein nach asymmetrischer Interaktion
EP1651964A2 (en) * 2003-07-31 2006-05-03 Hadasit Medical Research Services & Development Ltd. Methods and kits for the detection of prion diseases
MXPA06001588A (es) 2003-08-13 2006-08-25 Chiron Corp Reactivos de peptido especificos de prion.
US20060057671A1 (en) * 2004-09-10 2006-03-16 Orser Cindy S Immobilized probes and methods of detecting conformationally altered prion proteins
JP4568840B2 (ja) * 2004-12-28 2010-10-27 国立大学法人金沢大学 アルツハイマー病の検査方法
ATE528649T1 (de) * 2005-02-15 2011-10-15 Adlyfe Inc Verfahren zum nachweis falsch gefalteter proteine und prionen
US20060263767A1 (en) * 2005-04-20 2006-11-23 The Board Of Regents Of The University Of Texas System Ultrasensitive detection of prions by automated protein misfolding cyclic amplification
EP1731911A1 (fr) * 2005-06-07 2006-12-13 Institut National De La Sante Et De La Recherche Medicale (Inserm) Procédé utile pour la détection d'encéphalopathies
DE102005031429A1 (de) * 2005-07-04 2007-01-11 Heinrich-Heine-Universität Düsseldorf Verfahren zur selektiven Bestimmung pathologischer Proteinablagerungen
AU2006287299B2 (en) 2005-09-09 2012-08-23 Novartis Ag Prion-specific peptoid reagents
US20070281367A1 (en) 2006-05-03 2007-12-06 Applera Corporation Methods, Compositions, and Kits for Quantitating Antibodies
CA2657503C (en) 2006-07-28 2014-10-21 Adlyfe, Inc. Peptide probes for diagnostics and therapeutics
US20080118938A1 (en) * 2006-09-06 2008-05-22 Lisbell Estrada Methods and Compositions for the Detection of Protein Folding Disorders
US8216788B2 (en) * 2007-07-20 2012-07-10 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Detection of infectious prion protein by seeded conversion of recombinant prion protein
FR2929290B1 (fr) * 2008-03-27 2010-05-07 Lfb Biotechnologies Methode de detection et/ou de titrage in vitro d'un agent transmissible non conventionnel
EP2280029A4 (en) 2008-05-28 2014-10-01 Inc Admin Agency Naro METHOD FOR THE EFFICIENT REINFORCEMENT OF BSE DERIVED ABNORMAL PRION PROTEINS
JP5209711B2 (ja) 2008-05-28 2013-06-12 独立行政法人農業・食品産業技術総合研究機構 羊スクレイピー由来異常プリオン蛋白質の効率的増幅方法
ITMI20081052A1 (it) * 2008-06-10 2009-12-11 Univ Milano Bicocca Liposomi in grado di legare efficacemente il peptide beta-amiloide
FR2935711A1 (fr) * 2008-09-05 2010-03-12 Lfb Biotechnologies Clone cellulaire stable exprimant un prion
WO2011057029A1 (en) * 2009-11-04 2011-05-12 Novartis Ag Positively charged species as binding reagents in the separation of protein aggregates from monomers
US10989718B2 (en) 2014-09-11 2021-04-27 Amprion, Inc. Detection of misfolded alpha synuclein protein
US9910049B2 (en) 2014-09-11 2018-03-06 Amprion, Inc. Detection of misfolded amyloid beta protein
US10215763B2 (en) * 2010-05-18 2019-02-26 Board Of Regents Of The University Of Texas System Methods for estimating prion concentration in fluids and tissue by quantitative PMCA
IT1405762B1 (it) 2010-11-25 2014-01-24 Icgeb Proteine ricombinanti con attivita' di inattivazione selettiva di proteine bersaglio
EP2666020A1 (en) * 2011-01-18 2013-11-27 The United States of America, as represented by The Secretary, Department of Health and Human Services Methods for amplification and detection of prions
FR2973114A1 (fr) 2011-03-21 2012-09-28 Ets Francais Du Sang Nanobilles recouvertes de plasminogene comme support direct d'amplification cyclique de la proteine prion prpsc
WO2013056841A1 (en) 2011-10-19 2013-04-25 Inra (Institut National De La Recherche Agronomique) A method for diagnosing tse
WO2015160007A1 (ko) * 2014-04-17 2015-10-22 한림대학교 산학협력단 극미량 병원성 프리온 단백질 검출방법 및 장치
SG11201701953RA (en) 2014-09-11 2017-04-27 Univ Texas Detection of misfolded proteins
US10359434B2 (en) 2014-10-22 2019-07-23 Colorado State University Research Foundation In vitro detection of prions in blood
WO2016149537A1 (en) 2015-03-17 2016-09-22 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Bank vole prion protein as a broad-spectrum substrate for rt-quic-based detection and discrimination of prion strains
BR112019024138A2 (pt) 2017-05-16 2020-06-02 Amprion, Inc. Método para determinar uma presença ou ausência em uma amostra de um primeiro agregado de proteínas mal enoveladas
WO2019222554A2 (en) * 2018-05-16 2019-11-21 Amprion, Inc. Detection of brain injury or neurological disease using tau protein
BR112020024296A2 (pt) 2018-08-27 2021-03-09 Regeneron Pharmaceuticals, Inc. Métodos para produção de um intermediário de purificação de proteína concentrado, para monitoramento e controle dos atributos de qualidade críticos em um intermediário de purificação de proteína e para monitorar e controlar os níveis de excipientes no fluido de cultura de células colhido e/ou intermediário de purificação de proteína, e, intermediário de purificação de proteína
US11598783B1 (en) 2019-10-23 2023-03-07 Colorado State University Research Foundation In vitro detection of prions
WO2021198098A1 (en) * 2020-04-03 2021-10-07 Universität Zürich Improved method of detecting biomarkers in a biological sample

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262332A (en) * 1989-04-05 1993-11-16 Brigham And Women's Hospital Diagnostic method for Alzheimer's disease: examination of non-neural tissue
US5616871A (en) * 1995-09-28 1997-04-01 Drummond Scientific Company Pipet gun assembly
US5750361A (en) * 1995-11-02 1998-05-12 The Regents Of The University Of California Formation and use of prion protein (PRP) complexes
CA2268904A1 (en) * 1996-10-15 1998-04-23 Imperial College Of Science, Technology And Medicine Diagnosis of spongiform encephalopathy
WO2001000235A1 (en) 1999-06-29 2001-01-04 Mcgill University Prion protein binding proteins and uses thereof
JP2003517848A (ja) 1999-12-10 2003-06-03 ミソニクス インコーポレイテッド 超音波角アッセンブリ
US20060263767A1 (en) * 2005-04-20 2006-11-23 The Board Of Regents Of The University Of Texas System Ultrasensitive detection of prions by automated protein misfolding cyclic amplification

Also Published As

Publication number Publication date
DE60121958T2 (de) 2007-02-01
SI1712920T1 (sl) 2009-10-31
US7351526B2 (en) 2008-04-01
NO20030059D0 (no) 2003-01-06
DE60138146D1 (de) 2009-05-07
HUP0301020A2 (hu) 2003-07-28
YU101202A (sh) 2006-01-16
CA2413078C (en) 2010-08-03
IL153824A0 (en) 2003-07-31
KR20030036257A (ko) 2003-05-09
EA200300126A1 (ru) 2003-06-26
EP1712920B1 (en) 2009-03-25
DE60121958D1 (de) 2006-09-14
BRPI0112262B1 (pt) 2016-08-09
NO331624B1 (no) 2012-02-06
AU6408901A (en) 2002-01-21
CZ304365B6 (cs) 2014-04-02
HUP0301020A3 (en) 2010-03-29
HRP20030033B1 (hr) 2008-04-30
EP1299729B1 (en) 2006-08-02
NO20030059L (no) 2003-03-07
HU228813B1 (en) 2013-05-28
ES2322660T3 (es) 2009-06-24
ES2264691T3 (es) 2007-01-16
CA2413078A1 (en) 2002-01-17
MXPA03000226A (es) 2004-05-21
CN1449497A (zh) 2003-10-15
PT1299729E (pt) 2006-10-31
BRPI0112262B8 (pt) 2021-07-27
SK287768B6 (sk) 2011-09-05
CY1109106T1 (el) 2014-07-02
PL360397A1 (en) 2004-09-06
EP1712920A1 (en) 2006-10-18
RS51523B (sr) 2011-06-30
WO2002004954A3 (en) 2002-10-24
DK1299729T3 (da) 2006-12-04
IL153824A (en) 2010-02-17
PL211154B1 (pl) 2012-04-30
KR100764981B1 (ko) 2007-10-09
ATE335204T1 (de) 2006-08-15
WO2002004954A2 (en) 2002-01-17
BG66272B1 (bg) 2012-11-30
EP1299729A2 (en) 2003-04-09
BR0112262A (pt) 2003-05-20
BG107498A (bg) 2003-11-28
US20050064505A1 (en) 2005-03-24
JP2004503748A (ja) 2004-02-05
EA007391B1 (ru) 2006-10-27
CZ200336A3 (cs) 2003-06-18
HK1058065A1 (en) 2004-04-30
SK18582002A3 (sk) 2003-05-02
AU2001264089B2 (en) 2006-03-30
SI1299729T1 (sl) 2006-10-31
HRP20030033A2 (en) 2004-02-29
DK1712920T3 (da) 2009-05-11
EE05675B1 (et) 2013-08-15
AR029583A1 (es) 2003-07-02
ATE426816T1 (de) 2009-04-15
NZ523213A (en) 2005-01-28
JP4790966B2 (ja) 2011-10-12
PT1712920E (pt) 2009-04-09
CN1221807C (zh) 2005-10-05

Similar Documents

Publication Publication Date Title
EE200300005A (et) Meetod konformse haiguse diagnoosimiseks või tuvastamiseks, selleks vajalik katsemenetlus, reaktiivikomplekt ning seade
FI20011877L (fi) Menetelmä ja bioanturi analyysiä varten
ATE514945T1 (de) Diagnoseverfahren für maul- und klauenseuche und diagnostischer kit
DE60107322D1 (de) Apparat und Methode zur Normalisung biometrischer Bewertungsmasse
AU2002346484A1 (en) Method and apparatus for improving the accuracy of alternative site analyte concentration measurements
ITRM20030386A0 (it) Metodo e test diagnostici basati sull'analisi citofluorimetrica dei linfociti t antigene-specifici.
PL355271A1 (en) Test strip, an apparatus and as analytic kit for determining analyte concentration as well method of determining concentration of analyte in a physiological sample
FI990559A0 (fi) Näytteenkäsittelymenetelmä ja diagnostinen mittauslaite
NO20016364D0 (no) Fremgangsmåte og anordning for noninvasiv blodanalysemåling
ATE336942T1 (de) Vorrichtung zur entnahme biologischer flüssigkeiten und analytenmessung
PL355270A1 (en) Method of determining concentration of analyte in a sample as well as a measuring instrument and its associated apparatus for determining concentration of analyte in a sample
DE60133982D1 (de) Biosensor und verfahren zum analysieren von blutkomponenten
AU2002367597A8 (en) System, method and apparatus for the rapid detection and analysis of airborne biological agents
DE602004018575D1 (de) Chirurgisches Ultraschallsystem und Probe
NO20025702L (no) Todelt stråle FTIR-metoder og anordning for anvendelse i analyttdeteksjon ipröver med lav transmissivitet
EP1450668A4 (en) METHOD AND APPARATUS FOR DETECTION OF NEUROMUSCULAR DISEASES BY ANALYSIS OF NEUROMUSCULAR RESPONSES SUSCITED SPECIFIC TO SUCH DISEASES.
EP1291643A4 (en) METHOD AND APPARATUS FOR MEASURING FLUORESCENCE, AND APPARATUS FOR EVALUATING SAMPLE USING MEASURING APPARATUS
FR2810444B1 (fr) Dispositif de collimation, appareil de radiologie, kit de test et procede de test d'un appareil de radiologie
AU2003289853A8 (en) Methods, device and instrument for detection of analytes
DE69934983D1 (de) Verfahren, vorrichtung und bildgebungsmodus für tomographische bildgebung
FI20015015L (fi) Menetelmä ja laitteisto analyyttien kvalitatiiviseksi ja kvantitatiiviseksi osoittamiseksi
DE19983966T1 (de) Immunodiagnostisches Testverfahren für eine Tierkrankheit
ATE500272T1 (de) Angereicherter antikörper zur detektion von mikrobakterieller infektion, verfahren zur anwendung und diagnosetest damit
ITMI20001002A0 (it) Metodo e apparecchiatura per la diagnosi precoce di tumori vescicali su campioni di urina
EP1442296A4 (en) BIOLOGICAL ASSAY DETECTION PROCEDURE

Legal Events

Date Code Title Description
GB1A Change in the ownership or in the address of the owner
HC1A Change of owner name